| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $1.48B | $1.52B | $1.57B |
| YoY Revenue Growth % | -2.6% | -3.5% | — |
| Gross Profit | $897.7M | $954.6M | — |
| Gross Margin % | 60.7% | 62.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$31.3M | $119.0M | $81.0M |
| Operating Margin % | -2.1% | 7.8% | 5.2% |
| Net Income (GAAP) | -$27.9M | $93.0M | $60.7M |
| EBITDA (Normalized) | $55.4M | $226.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $119.6M | $194.0M | $244.3M |
| Capital Expenditures (CapEx) | $108.3M | $134.2M | — |
| Free Cash Flow (FCF) | $11.3M | $59.8M | $244.3M |
| FCF Margin % | 0.8% | 3.9% | 15.5% |
| Return on Invested Capital (ROIC %) | -4.0% | 14.6% | — |
| Cash & Short-Term Equivalents | $8.1M | $9.5M | — |
| Total Debt (Short + Long Term) | $116.4M | $31.1M | — |
| Total Stockholders' Equity | $514.8M | $622.6M | — |